The immunology, imaging, and informatics in precision immunomedicine (iPRIME) initiative awarded a 2-year pilot grant to Dr. Civelek and Dr. Patricia Rodriguez Lozano, Director of Women’s Heart Health Program at UVA, to study the impact of sodium-glucose cotransporter 2 inhibitors on systemic inflammation in women with coronary microvascular disease.